BioNTech SE

NASDAQ: BNTX
$80.09
+$0.23 (+0.3%)
Closing Price on July 5, 2024

BNTX Chart and Intraday Price

BNTX Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address AN DER GOLDGRUBE 12, MAINZ, DE
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 21,617.89M USD
Shares Outstanding 237,716,000
BioNTech SE is a pioneering biotechnology firm from Mainz, Germany, known for its innovative work in developing immunotherapies for a range of serious diseases, including cancer and infectious diseases. The company is at the forefront of creating treatments such as vaccines and therapies, with several products in various stages of clinical trials targeting conditions like melanoma, prostate cancer, and lung cancer. BioNTech is also notable for its collaborations with major pharmaceutical companies, enhancing its research and development capabilities in the quest to combat challenging diseases.

BNTX Articles

With the pandemic largely in the rear-view mirror, COVID-19 vaccine winner Novavax has seen shares fall. Yet, analysts have high hopes for the stock.
Thursday's top analyst upgrades and downgrades included Analog Devices, AppLovin, Goodyear Tire & Rubber, Home Depot, iQIYI, Knight-Swift Transportation, Kohl’s, Lowe's Companies, Marriott...
A major media company reports results early Friday morning, while a biotech and a food products company will report before Monday's opening bell.
Tuesday's top analyst upgrades and downgrades included Alphabet, Caterpillar, Corning, Digital Realty Trust, Dish Network, KeyCorp, Nvidia, Pinterest, Roku, Tesla and Wynn Resorts.
There are no notable earnings reports due Friday. Before U.S. markets open on Monday, a drug maker and a cruise line operator are on deck to report quarterly results.
Friday's top analyst upgrades and downgrades included AT&T, Baxter International, Delta Air Lines, DXC Technology, JetBlue Airways, Marriott International, MongoDB, PPL, RingCentral, Snap, Snowflake,...
Wednesday's additional top analyst upgrades and downgrades included Bath & Body Works, BioNTech, Caesars, Freeport McMoRan, Gap, Hasbro, and Synchrony Financial.
Here are previews of four interesting companies set to report quarterly results after the markets close on Tuesday and before they open on Wednesday.
Tuesday's top analyst upgrades and downgrades included BioNTech, ConocoPhillips, Harley-Davidson, Livent, Luminar Technologies, Meta Platforms, Moderna, Snap, Twitter, United Airlines, US Foods,...
Thursday afternoon's top analyst upgrades and downgrades included AT&T, BioNTech, Chewy, DocuSign, Ford, GM, Shopify, Toast, and more.
Wednesday afternoon's analyst upgrades and downgrades included BioNTech, ConocoPhillips, Casper Sleep, DoorDash, Palantir and Poshmark.
Here are three companies scheduled to report quarterly results before markets open on Tuesday.
Thursday afternoon's analyst upgrades and downgrades included Amazon, Bank of America, BioNTech, Chipotle, Disney and more.
COVID-19 vaccine co-developer BioNTech reports June quarter earnings before markets open Monday morning. So do two hot stocks in Cathie Wood's ETF portfolio.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Acceleron Pharma, BioNTech, CyberArk Software, Five9 and Vertex Pharmaceuticals.